Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases

Cédric Chauvierre (1) , Rachida Aid-Launais (1) , Joël Aerts (2) , Frederic Chaubet (1) , Murielle Maire (1) , Lucas Chollet , Lydia Rolland , Roberta Bonafé (3) , Silvia Rossi (3) , Simona Bussi (3) , Claudia Cabella (3) , Laszlo Dézsi (4) , Tamas Fulop (4) , Janos Szebeni (4) , Youssef Chahid (5) , Kang Zheng (5) , Erik Stroes (5) , Dominique Le Guludec (6) , François Rouzet (6) , Didier Letourneur (1)

1 LVTS (UMR_S_1148 / U1148) - Laboratoire de Recherche Vasculaire Translationnelle
2 UMS34 FRIM - Fédération de Recherche en Imagerie Multimodalité [Paris]
3 Bracco Research SpA
4 Semmelweis University [Budapest, Hungary]
5 AMC - Academic Medical Center - Academisch Medisch Centrum [Amsterdam]
6 Service de Médecine Nucléaire [Paris 18eme]

Mots clés: scintigraphy, regulatory toxicology, molecular diagnosis, GMP-grade fucoidan

Domaines: Pharmacie galénique

Cédric Chauvierre, Rachida Aid-Launais, Joël Aerts, Frederic Chaubet, Murielle Maire, et al.. Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases. Marine drugs, 2019, 17 (12), pp.699. ⟨10.3390/md17120699⟩. ⟨hal-02438440⟩